Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −14 $374.44 $5K 23,588
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −19 $375.65 $7K 23,569
2026-01-12 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −15 $377.82 $6K 23,554
2026-01-11 Garg Pushkal EVP Chief R&D Grant or award +3,800 24,021
2026-01-11 Greenstreet Yvonne Chief Executive Officer Grant or award +19,003 87,988
2026-01-11 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award +6,193 60,245
2026-01-11 Tanguler Tolga EVP, Chief Commercial Officer Grant or award +3,800 31,238
2026-01-11 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Grant or award 10b5-1 +3,800 25,064
2026-01-05 Arbuckle Stuart A Director Grant or award · Stock Option (right to buy) +3,279 3,279
2025-11-26 Greenstreet Yvonne Chief Executive Officer Option exercise +839 $119.13 $100K 66,248
2025-11-26 Greenstreet Yvonne Chief Executive Officer Option exercise +2,352 $85.00 $200K 68,600
2025-11-26 Greenstreet Yvonne Chief Executive Officer Option exercise +847 $118.05 $100K 69,447
2025-11-26 Greenstreet Yvonne Chief Executive Officer Option exercise +659 $151.59 $100K 70,106
2025-11-26 Greenstreet Yvonne Chief Executive Officer Shares withheld for taxes −1,121 $445.12 $499K 68,985
2025-11-26 Greenstreet Yvonne Chief Executive Officer Option exercise · Stock Option (right to buy) −2,352 0
2025-11-26 Greenstreet Yvonne Chief Executive Officer Option exercise · Stock Option (right to buy) −847 0
2025-11-26 Greenstreet Yvonne Chief Executive Officer Option exercise · Stock Option (right to buy) −839 0
2025-11-26 Greenstreet Yvonne Chief Executive Officer Option exercise · Stock Option (right to buy) −659 28,141
2025-11-17 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Option exercise 10b5-1 +8,161 $119.13 $972K 33,392
2025-11-17 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −8,168 $449.00 $3.7M 25,224

Page 16 of 41 · 816 trades